Stahl Neil

Avg. Two Year Performance

No purchase track record
(39%) Avg. Sale Return
(18%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(1%)1%(7%)(17%)(39%)
Sale Success Rate11 of 3015 of 308 of 306 of 306 of 30
Drugs » Biotechnology

EVP Research and Development:

Holdings: 60.05K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--